C(O)(=O)C.[CH3:5][O:6][C:7]1[CH:8]=[C:9]([CH:12]=[CH:13][C:14]=1[O:15][CH2:16][CH2:17][C:18]1[S:22][CH:21]=[N:20][C:19]=1[CH3:23])[CH:10]=O.[CH2:24]1[CH2:31][CH:30]([NH2:32])[C:28](=[O:29])[NH:27][CH2:26][CH2:25]1>CO>[CH3:5][O:6][C:7]1[CH:8]=[C:9]([CH:12]=[CH:13][C:14]=1[O:15][CH2:16][CH2:17][C:18]1[S:22][CH:21]=[N:20][C:19]=1[CH3:23])[CH2:10][NH:32][CH:30]1[CH2:31][CH2:24][CH2:25][CH2:26][NH:27][C:28]1=[O:29]Acetic acid (9.4 mmol) was added to 3-Methoxy-4-[2-(4-methyl-thiazol-5-yl)-ethoxy]-benzaldehyde (6) (2.3 mmol) and DL-α-amino-ε-caprolactam (2.3 mmol) in minimal amount of methanol and stirred for 2 h. MeOH (0.2 M) was added followed by NaH3BCN (2.3 mmol), and the reaction was stirred for 19 h. The product (7) was obtained by purification upon reverse phase HPLC.